Clinical experience with cefpodoxime proxetil in acute otitis media
1Hôpital Intercommunal de Créteil, France.
Insights
Cefpodoxime proxetil demonstrates comparable or superior clinical efficacy compared to other antibiotics for treating childhood acute otitis media, offering a viable alternative amid rising antibiotic resistance.
Area of Science:
- Infectious Diseases
- Pediatrics
- Pharmacology
Background:
- Rising global antibiotic resistance in otitis-causing pathogens necessitates alternative treatments.
- Amoxicillin remains a common reference treatment, but resistance is a growing concern.
- Cefpodoxime proxetil emerges as a potential therapeutic alternative.
Purpose of the Study:
- To evaluate the clinical efficacy of cefpodoxime proxetil in pediatric acute otitis media.
- To compare cefpodoxime proxetil with other antibiotics like amoxicillin/clavulanic acid and cefixime.
- To assess the effectiveness of cefpodoxime proxetil in the context of increasing antibiotic resistance.
Main Methods:
- Six comparative randomized trials involving 1188 children (2 months to 12 years) were analyzed.
- Patients received either cefpodoxime proxetil (5-day treatment) or comparator drugs (amoxicillin/clavulanic acid, cefaclor, cefixime; 10-day treatment).
- Clinical efficacy, healing rates, tympanogram status, and microbiological data were assessed.
Main Results:
- Cefpodoxime proxetil showed clinical efficacy at least equivalent to comparators in 4 trials and superior in 2 trials.
- Superiority was observed against amoxicillin/clavulanic acid regarding healing and normal tympanograms.
- Better healing rates in febrile and painful acute otitis media were noted compared to cefixime.
Conclusions:
- Cefpodoxime proxetil is an effective alternative for childhood acute otitis media, especially against resistant strains.
- Its efficacy is comparable or superior to established treatments, with favorable pharmacokinetic and microbiologic profiles.
- Further research may solidify its role in combating antibiotic resistance in otitis treatment.
Abstract:
Although it varies from country to country, there is a worrying worldwide increase in antibiotic resistance among pathogens causing otitis. This has led to a search for therapeutic alternatives to the reference treatment, which is still amoxicillin in many countries. Cefpodoxime proxetil is one such alternative. Six comparative randomized trials of cefpodoxime proxetil in childhood acute otitis media have been published or presented at international conferences. They involved a total of 1188 patients, 658 of whom received cefpodoxime proxetil and 530 of whom received the comparator drug (amoxicillin/clavulanic acid in 3 trials, cefaclor in 1, and cefixime in 2); duration of treatment varied from 5 days for cefpodoxime proxetil to 10 days for amoxicillin/clavulanic acid, and the age of the children included ranged from 2 months to 12 years. The clinical efficacy of cefpodoxime proxetil was at least equivalent to that of the comparators in 4 trials and significantly better in 2 trials. Firstly, in one study vs. amoxicillin/clavulanic acid, the superiority of cefpodoxime proxetil (8 mg/kg/day twice daily) in terms of healing at the end of treatment and in terms of the number of normal tympanograms at the follow-up visit was shown. Secondly, in a study performed by our group, vs. cefixime, cefpodoxime proxetil (8 mg/kg/day twice daily) showed a better healing rate at the end of treatment in febrile and painful acute otitis media. The microbiologic and pharmacokinetic data show that cefpodoxime proxetil is one of the most active compounds against Haemophilus influenzae and Streptococcus pneumoniae.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:26Tonsillitis II: Management
01:27Acute Pyelonephritis I: Introduction
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:27Streptococcal Pharyngitis